Diagnosis of stomach cancer (also known as gastric cancer) is now occurring more often at earlier stages, likely related to advances in tests and imaging. Importantly, stomach cancer is also being ...

The five-year survival rate has jumped up from around 75% to over 90%. Since the start of Breast Cancer Awareness initiatives in 1985, over 517,000 lives have been saved from better treatment and ...

Gastric cancer often develops through a gradual sequence of changes, beginning with superficial gastritis and advancing through chronic atrophic gastritis, intestinal metaplasia, and precancerous ...

Gastric cancer is one of the leading causes of cancer-related mortality worldwide, and peritoneal metastasis, wherein the cancer spreads to the peritoneum or the lining of the abdominal cavity, ...

Gastric cancer, one of the leading causes of cancer-related mortality globally, faces challenges in treatment due to limitations in surgery, chemotherapy resistance, and high recurrence rates.

Researchers are estimating 15.6 million lifetime gastric cancer cases globally, with more than three-quarters attributable to Helicobacter pylori, among young people, according to a study published in ...

Share on Pinterest About three-quarters of gastric cancer cases worldwide have been linked to the common bacteria H. pylori. Courtney Hale/Getty Images The vast majority of stomach cancer cases have ...

Adcentrx Therapeutics advances gastric cancer treatment with FDA orphan drug designation for ADRX-0405, a promising antibody-drug conjugate in clinical trials. The FDA has granted orphan drug ...

1 Department of Surgery and Anesthesiology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nangjing, China 2 Department of Anesthesiology, Huainan First People’s Hospital, The First ...

New findings reveal bemarituzumab plus chemotherapy significantly improves survival in advanced gastric cancer, offering hope for targeted treatment options. First-line treatment with bemarituzumab ...